Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.

about

Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.

Item

http://www.wikidata.org/entity/Q47261001

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Under-utilisation of high-dose ...... th external beam radiotherapy.

@en

Under-utilisation of high-dose ...... th external beam radiotherapy.

@nl

type

Item

label

Under-utilisation of high-dose ...... th external beam radiotherapy.

@en

Under-utilisation of high-dose ...... th external beam radiotherapy.

@nl

prefLabel

Under-utilisation of high-dose ...... th external beam radiotherapy.

@en

Under-utilisation of high-dose ...... th external beam radiotherapy.

@nl

P1476

Under-utilisation of high-dose ...... th external beam radiotherapy.

@en

P2860

The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base

Using linked routinely collected health data to describe prostate cancer treatment in New South Wales, Australia: a validation study

Adverse effects of androgen deprivation therapy and strategies to mitigate them.

Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.

Significant association of brachytherapy boost with reduced prostate cancer-specific mortality in contemporary patients with localized, unfavorable-risk prostate cancer.

Resident-reported brachytherapy experience in ACGME-accredited radiation oncology training programs.

The decreased use of brachytherapy boost for intermediate and high-risk prostate cancer despite evidence supporting its effectiveness.

Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam B

Brachytherapy for Patients With Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update.

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

P31

scholarly article

P356

10.1111/1754-9485.12699

http://www.w3.org/2001/XMLSchema#string

P50

Sue M. Evans

Jeremy Millar

Wee Loon Ong

P577

2017-12-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29271056

http://www.w3.org/2001/XMLSchema#string

P921

brachytherapy